Altimmune (ALT) Non-Current Deferred Tax Liability (2017 - 2019)

Altimmune (ALT) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $58500.0 in Q2 2019.

• Non-Current Deferred Tax Liability for Q2 2019 came in at $58500.0, down 98.68% year-over-year; the trailing twelve-month figure through Jun 2019 was $58500.0 (down 98.68% YoY), and the FY2018 annual result was $58500.0, down 99.01% from the prior year.
• Non-Current Deferred Tax Liability held at $58500.0 in Q2 2019 per ALT's latest filing, from $58500.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $8.5 million in Q2 2017 and troughed at $58500.0 in Q4 2018.
• A 3-year average of $4.0 million and a median of $4.4 million in 2018 frame the typical range for Non-Current Deferred Tax Liability.
• On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 48.14% in 2018 and fell as far as 99.01% in 2018.
• A 3-year view of Non-Current Deferred Tax Liability shows it stood at $5.9 million in 2017, then tumbled by 99.01% to $58500.0 in 2018, then changed by 0.0% to $58500.0 in 2019.
• Business Quant data shows ALT's Non-Current Deferred Tax Liability at $58500.0 in Q2 2019, $58500.0 in Q1 2019, and $58500.0 in Q4 2018.